Analysis of the Expression and Regulation of PD-1 Protein on the Surface of Myeloid-Derived Suppressor Cells (MDSCs) |
Nam, Sorim
(Division of Biological Sciences, Research Institute of Women's Health and Cellular Heterogeneity Research Center, Sookmyung Women's University)
Lee, Aram (Division of Biological Sciences, Research Institute of Women's Health and Cellular Heterogeneity Research Center, Sookmyung Women's University) Lim, Jihyun (Division of Biological Sciences, Research Institute of Women's Health and Cellular Heterogeneity Research Center, Sookmyung Women's University) Lim, Jong-Seok (Division of Biological Sciences, Research Institute of Women's Health and Cellular Heterogeneity Research Center, Sookmyung Women's University) |
1 | Jiang, M., Chen, J., Zhang, W., Zhang, R., Ye, Y., Liu, P., Yu, W., Wei, F., Ren, X. and Yu, J. (2017) Interleukin-6 trans-signaling pathway promotes immunosuppressive myeloid-derived suppressor cells via suppression of suppressor of cytokine signaling 3 in breast cancer. Front. Immunol. 8, 1840. DOI |
2 | Karyampudi, L., Lamichhane, P., Krempski, J., Kalli, K. R., Behrens, M. D., Vargas, D. M., Hartmann, L. C., Janco, J. M., Dong, H., Hedin, K. E., Dietz, A. B., Goode, E. L. and Knutson, K. L. (2016) PD-1 Blunts the Function of Ovarian Tumor-Infiltrating Dendritic Cells by Inactivating NF-kappaB. Cancer Res. 76, 239-250. DOI |
3 | Kumar, V., Patel, S., Tcyganov, E. and Gabrilovich, D. I. (2016) The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol. 37, 208-220. DOI |
4 | Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C. and Hermoso, M. A. (2014) Chronic inflammation and cytokines in the tumor microenvironment. J. Immunol. Res. 2014, 149185. DOI |
5 | Leung, J. and Suh, W. K. (2014) The CD28-B7 family in anti-tumor immunity: emerging concepts in cancer immunotherapy. Immune Netw. 14, 265-276. DOI |
6 | Lewis, A. M., Varghese, S., Xu, H. and Alexander, H. R. (2006) Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J. Transl. Med. 4, 48. DOI |
7 | Liu, Y., Yu, Y., Yang, S., Zeng, B., Zhang, Z., Jiao, G., Zhang, Y., Cai, L. and Yang, R. (2009) Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells. Cancer Immunol. Immunother. 58, 687-697. DOI |
8 | Nam, S., Kang, K., Cha, J. S., Kim, J. W., Lee, H. G., Kim, Y., Yang, Y., Lee, M. S. and Lim, J. S. (2016) Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function. J. Leukoc. Biol. 100, 1273-1284. DOI |
9 | Robertson, S. E., Young, J. D., Kitson, S., Pitt, A., Evans, J., Roes, J., Karaoglu, D., Santora, L., Ghayur, T., Liew, F. Y., Gracie, J. A. and McInnes, I. B. (2006) Expression and alternative processing of IL-18 in human neutrophils. Eur. J. Immunol. 36, 722-731. DOI |
10 | Poschke, I., Mougiakakos, D., Hansson, J., Masucci, G. V. and Kiessling, R. (2010) Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res. 70, 4335-4345. DOI |
11 | Said, E. A., Dupuy, F. P., Trautmann, L., Zhang, Y., Shi, Y., El-Far, M., Hill, B. J., Noto, A., Ancuta, P., Peretz, Y., Fonseca, S. G., Van Grevenynghe, J., Boulassel, M. R., Bruneau, J., Shoukry, N. H., Routy, J. P., Douek, D. C., Haddad, E. K. and Sekaly, R. P. (2010) Programmed death-1-induced interleukin-10 production by monocytes impairs T cell activation during HIV infection. Nat. Med. 16, 452-459. DOI |
12 | Shin, J. and Jin, M. (2017) Potential immunotherapeutics for immunosuppression in sepsis. Biomol. Ther. (Seoul) 25, 569-577. DOI |
13 | Sinha, P., Okoro, C., Foell, D., Freeze, H. H., Ostrand-Rosenberg, S. and Srikrishna, G. (2008) Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J. Immunol. 181, 4666-4675. DOI |
14 | Terme, M., Ullrich, E., Aymeric, L., Meinhardt, K., Desbois, M., Delahaye, N., Viaud, S., Ryffel, B., Yagita, H., Kaplanski, G., Prevost-Blondel, A., Kato, M., Schultze, J. L., Tartour, E., Kroemer, G., Chaput, N. and Zitvogel, L. (2011) IL-18 induces PD-1-dependent immunosuppression in cancer. Cancer Res. 71, 5393-5399. DOI |
15 | Trikha, P. and Carson, W. E., 3rd (2014) Signaling pathways involved in MDSC regulation. Biochim. Biophys. Acta 1846, 55-65. |
16 | Condamine, T. and Gabrilovich, D. I. (2011) Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 32, 19-25. DOI |
17 | Ahmadzadeh, M., Johnson, L. A., Heemskerk, B., Wunderlich, J. R., Dudley, M. E., White, D. E. and Rosenberg, S. A. (2009) Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 114, 1537-1544. DOI |
18 | Bai, J., Gao, Z., Li, X., Dong, L., Han, W. and Nie, J. (2017) Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade. Oncotarget 8, 110693-110707. DOI |
19 | Bally, A. P., Lu, P., Tang, Y., Austin, J. W., Scharer, C. D., Ahmed, R. and Boss, J. M. (2015) NF-kappaB regulates PD-1 expression in macrophages. J. Immunol. 194, 4545-4554. DOI |
20 | Daud, A. I., Loo, K., Pauli, M. L., Sanchez-Rodriguez, R., Sandoval, P. M., Taravati, K., Tsai, K., Nosrati, A., Nardo, L., Alvarado, M. D., Algazi, A. P., Pampaloni, M. H., Lobach, I. V., Hwang, J., Pierce, R. H., Gratz, I. K., Krummel, M. F. and Rosenblum, M. D. (2016) Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma. J. Clin. Invest. 126, 3447-3452. DOI |
21 | Yang, L. and Zhang, Y. (2017) Tumor-associated macrophages: from basic research to clinical application. J. Hematol. Oncol. 10, 58. DOI |
22 | Tu, S., Bhagat, G., Cui, G., Takaishi, S., Kurt-Jones, E. A., Rickman, B., Betz, K. S., Penz-Oesterreicher, M., Bjorkdahl, O., Fox, J. G. and Wang, T. C. (2008) Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 14, 408-419. DOI |
23 | Umansky, V., Blattner, C., Gebhardt, C. and Utikal, J. (2016) The role of myeloid-derived suppressor cells (MDSC) in cancer progression. Vaccines (Basel) 4, E36. DOI |
24 | Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T., Tsuchiya, H., Pardoll, D. M., Okumura, K., Azuma, M. and Yagita, H. (2002) Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169, 5538-5545. DOI |
25 | Yang, R., Cai, Z., Zhang, Y., Yutzy, W. H. t., Roby, K. F. and Roden, R. B. (2006) CD80 in immune suppression by mouse ovarian carcinoma-associated myeloid cells. Cancer Res. 66, 6807-6815. DOI |
26 | Yao, S., Wang, S., Zhu, Y., Luo, L., Zhu, G., Flies, S., Xu, H., Ruff, W., Broadwater, M., Choi, I. H., Tamada, K. and Chen, L. (2009) PD-1 on dendritic cells impedes innate immunity against bacterial infection. Blood 113, 5811-5818. DOI |
27 | Zamani, M. R., Aslani, S., Salmaninejad, A., Javan, M. R. and Rezaei, N. (2016) PD-1/PD-L and autoimmunity: a growing relationship. Cell Immunol. 310, 27-41. DOI |
28 | Fabbi, M., Carbotti, G. and Ferrini, S. (2015) Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP. J. Leukoc. Biol. 97, 665-675. DOI |
29 | Zhang, Y., Zhou, Y., Lou, J., Li, J., Bo, L., Zhu, K., Wan, X., Deng, X. and Cai, Z. (2010) PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit. Care 14, R220. DOI |
30 | Draghiciu, O., Lubbers, J., Nijman, H. W. and Daemen, T. (2015) Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy. Oncoimmunology 4, e954829. DOI |
31 | Gabrilovich, D. I., Ostrand-Rosenberg, S. and Bronte, V. (2012) Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253-268. DOI |
32 | Gordon, S. R., Maute, R. L., Dulken, B. W., Hutter, G., George, B. M., McCracken, M. N., Gupta, R., Tsai, J. M., Sinha, R., Corey, D., Ring, A. M., Connolly, A. J. and Weissman, I. L. (2017) PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545, 495-499. DOI |
33 | Hoesel, B. and Schmid, J. A. (2013) The complexity of NF-kappaB signaling in inflammation and cancer. Mol. Cancer 12, 86. DOI |
34 | Hu, X., Li, B., Li, X., Zhao, X., Wan, L., Lin, G., Yu, M., Wang, J., Jiang, X., Feng, W., Qin, Z., Yin, B. and Li, Z. (2014) Transmembrane TNF-alpha promotes suppressive activities of myeloid-derived suppressor cells via TNFR2. J. Immunol. 192, 1320-1331. DOI |
35 | Huang, B., Lei, Z., Zhao, J., Gong, W., Liu, J., Chen, Z., Liu, Y., Li, D., Yuan, Y., Zhang, G. M. and Feng, Z. H. (2007) CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers. Cancer Lett. 252, 86-92. DOI |
36 | Huang, A., Zhang, B., Yan, W., Wang, B., Wei, H., Zhang, F., Wu, L., Fan, K. and Guo, Y. (2014) Myeloid-derived suppressor cells regulate immune response in patients with chronic hepatitis B virus infection through PD-1-induced IL-10. J. Immunol. 193, 5461-5469. DOI |